Campus alert status is green: For the latest UMMS campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search
Search Close Search

Supporting the boldest research ideas in the interdisciplinary labs under the direction of Robert H. Brown Jr., DPhil, MD, one of the world's foremost authorities on ALS.

Boston Marathon 2021

This year's event will take place on Monday, Oct. 11., and the UMass ALS Cellucci Fund team will once again have five runners! Meet the team.


marathon generic 200H.png

SPONSOR the Boston Marathon 2021 Cellucci Fund Team

Your organization can provide hope to those affected by ALS with something very rare and very needed: HOPE. Your organization can sponsor this year's team in their fundraising efforts.

 

Details here

mueller-brown 435x225.png

Silencing of an ALS gene safely delivered to patients in UMass Medical School study

Synthetic microRNA treatment targets mutant SOD1 gene that causes ALS

UMass Medical School and Massachusetts General Hospital are the first to safely treat two research participants with a synthetic microRNA, delivered into the spinal fluid, designed to silence a human disease-causing gene. Details of the treatment appear in the New England Journal of Medicine.

Read more
Page Menu